Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Delivering the Right Therapy to the Right Patient with ADCs

Posted on August 11th, 2017 by in Pharma R&D

One of the most powerful tools in the fight against cancer has become the patient’s very own immune system. Among the many approaches that researchers are exploring is the use of antibody-drug conjugates (ADCs) Continue reading “Delivering the Right Therapy to the Right Patient with ADCs” »

Is a new Alzheimer’s disease drug in the offing?

Posted on September 23rd, 2016 by in Pharma R&D

A high profile paper describing a prospective new therapy for Alzheimer’s disease (AD) was being shared around the internet recently. The paper, “The antibody aducanumab reduces Ab plaques in Alzheimer’s disease,” authored by Sevigny et al., was published on-line in Nature (Sevigny et al., 2016) and describes the preclinical and early clinical development of aducanumab, Continue reading “Is a new Alzheimer’s disease drug in the offing?” »

Impact of Precision Medicine and Genomics on Patient Treatment

Posted on August 26th, 2016 by in Chemistry

In January of 2015, President Barack Obama launched the Precision Medicine Initiative, which brought to the forefront the growing understanding and need for individually tailored and customized treatments for patients.

Continue reading “Impact of Precision Medicine and Genomics on Patient Treatment” »

A gathering of global perspectives ….. a look at DIA’s annual meeting: Post 1 of 2

Posted on July 11th, 2016 by in Pharma R&D

At the end of June, the Drug Information Association (DIA), held its annual conference with this year’s theme being “A Gathering of Global Perspectives.”  The meeting, held in Philadelphia, offered a wide variety of tracks from which you could “pick and mix” Continue reading “A gathering of global perspectives ….. a look at DIA’s annual meeting: Post 1 of 2” »

  1. 1
  2. 2